← Every firm
Cipla FDA Recalls
7 recalls on file across drugs, 0 of them Class I and 0 still open. This firm is not matched to a listed company.
Newest first
Class I is the FDA's most serious grade: a reasonable probability of serious harm or death.
| Product |
|---|
| Arformoterol Tartrate Inhalation Solution, 15 mcg/2mL, 2 mL Sterile Unit-Dose Vial packaged in 5 x 2 mL Sterile Unit-DosClass IISep 29, 2022Lack of Assurance of Sterility: environmental monitoring fai |
| Budesonide Inhalation Suspension 0.25mg/2mL, For Inhalation Only, Rx Only, 1 envelope x five 2 mL Single Dose Ampules peClass IISep 15, 2022Lack of Assurance of Sterility |
| Difluprednate Ophthalmic Emulsion, 0.05%, 5 mL bottle, RX only, Manufactured for Exelan Pharmecuticals, Inc., Boca RatonClass IIAug 22, 2022Lack of Assurance of Sterility: customer complaint for defec |
| Difluprednate Ophthalmic Emulsion, 0.05%, 5 mL bottle, RX only, Manufactured by Cipla Ltd., India, Manufactured for: CipClass IIAug 22, 2022Lack of Assurance of Sterility: customer complaint for defec |
| Difluprednate Ophthalmic Emulsion 0.05%, For Ophthalmic Use Only, Sterile, 5 mL bottles, Manufactured by Cipla Ltd., IndClass IIAug 2, 2022Lack of Assurance of Sterility: Complaints received of defec |
| Difluprednate Ophthalmic Emulsion, 0.05%, 5ml bottles, Rx only, Mfd. by: Cipla Ltd., India At M/S Indoco Remedies LimiteClass IIJul 14, 2022Lack of Assurance of Sterility: customer complaint for defec |
| Solifenacin Succinate Tablets, 10 mg, 30-count bottles, Rx Only, Manufactured by: Cipla Ltd., Verna, Goa, India ManufactClass IIJun 10, 2021CGMP Deviations |